MONTRONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.401
EU - Europa 1.437
AS - Asia 857
SA - Sud America 148
AF - Africa 20
OC - Oceania 7
Totale 4.870
Nazione #
US - Stati Uniti d'America 2.388
SG - Singapore 374
SE - Svezia 369
UA - Ucraina 286
CN - Cina 190
DE - Germania 165
IE - Irlanda 146
BR - Brasile 123
RU - Federazione Russa 123
DK - Danimarca 101
HK - Hong Kong 87
GB - Regno Unito 71
KR - Corea 66
TR - Turchia 61
FI - Finlandia 60
FR - Francia 45
VN - Vietnam 37
IT - Italia 34
BE - Belgio 15
IN - India 14
AR - Argentina 9
CA - Canada 7
ZA - Sudafrica 6
AT - Austria 5
BD - Bangladesh 5
NL - Olanda 5
CI - Costa d'Avorio 4
CO - Colombia 4
NZ - Nuova Zelanda 4
PL - Polonia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
EC - Ecuador 3
EG - Egitto 3
JP - Giappone 3
KE - Kenya 3
MA - Marocco 3
MX - Messico 3
AL - Albania 2
CL - Cile 2
IQ - Iraq 2
KZ - Kazakistan 2
NO - Norvegia 2
RO - Romania 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BB - Barbados 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ES - Italia 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
Totale 4.870
Città #
Chandler 347
Jacksonville 286
Singapore 236
Boardman 158
Ashburn 154
Dublin 146
Wilmington 142
Fairfield 120
Hong Kong 87
Dallas 85
Ann Arbor 70
Seattle 70
Houston 67
San Mateo 66
Woodbridge 64
Lawrence 58
Princeton 58
Beijing 57
Des Moines 52
Hefei 49
New York 42
Los Angeles 39
Buffalo 31
San Diego 25
Moscow 23
Cambridge 21
The Dalles 18
Brussels 15
Chicago 10
Auburn Hills 9
Hanoi 9
Ho Chi Minh City 9
Seoul 9
Phoenix 8
São Paulo 8
Norwalk 7
Washington 7
Chennai 6
Council Bluffs 6
Rio de Janeiro 6
Ankara 5
Santa Clara 5
Shanghai 5
Stockholm 5
Abidjan 4
Hanover 4
Johannesburg 4
London 4
Nuremberg 4
Warsaw 4
Charlotte 3
Denver 3
Guangzhou 3
Helsinki 3
Marche 3
Montreal 3
Munich 3
Nairobi 3
Porto Alegre 3
Pune 3
Quanzhou 3
San Francisco 3
Tokyo 3
Torre Annunziata 3
Wuhan 3
Almaty 2
Anápolis 2
Auckland 2
Baghdad 2
Barranquilla 2
Boston 2
Brasília 2
Brooklyn 2
Cachoeiro de Itapemirim 2
Cairo 2
Cape Town 2
Chapecó 2
Chittagong 2
Columbus 2
Cotia 2
Dalian 2
Dubai 2
Elk Grove Village 2
Frankfurt am Main 2
Guarulhos 2
Hortolândia 2
Itaquaquecetuba 2
Jaraguá do Sul 2
Lushnjë 2
Mexico City 2
Mumbai 2
Nam Định 2
Orem 2
Oslo 2
Poplar 2
Porto Velho 2
Ribeirão Preto 2
Sumaré 2
São Gonçalo 2
Tashkent 2
Totale 2.839
Nome #
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 140
Anticardiolipin antibodies expression in psoriasis 134
Higly active antiretroviral therapy induces specific changes in effector and central memory T cell sub-populations 132
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 127
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 120
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. 108
Effects of cryopreservation on lymphocyte immunophenotype and function 107
Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. 107
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. 103
Abnormal intracellular kinetics of cell –cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biological link between immune activation, accelerated T- cell turnover and high levels of apoptosis 102
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 100
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 98
Exogenous IL-2 administration corrects the cell cycle perturbation of lymphocytes from HIV-infected individuals 98
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? 97
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults; results of a 48-week open-label, equivalence trial (CAN 3014) 97
Il ruolo del Medico di Medicina Generale nella diagnosi precoce della malattia da HIV. 96
Diagnosi sierologica nelle malattie autoimmuni non organo-specifiche. 95
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. 92
Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study. 90
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. 90
Unscheduled cyclin B expression and p34 cdc2 activation in T-lymphocytes from HIV patients 88
Specific changes in the post-translational regulation of nucleolin in lymphocytes from patients infected with human immunodeficiency virus 88
Genotypic Resistance Tests for the Management of Structured Therapeutic Interruptions after Multiple Drug Failure: Prosecution 88
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naïve for Antiretrovirals 87
Interruption of antiretroviral therapy is associated with increased plasma cystatin C. 87
I vaccini, da Jenner ai vaccini a DNA 87
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. 86
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. 86
Lo studio fenotipico delle cellule mononucleate, linee guida all'impiego clinico, alla lettura ed all'interpretazione nelle diverse condizioni morbose. 82
Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. 82
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. 81
Sexual behaviour of heterosexual individuals with HIV infection naïve for antiretroviral therapy in Italy . 80
Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status 80
HIV-induced abnormalities in myelopoiesis and their recovery following antiretroviral therapy 79
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 79
Lo studio fenotipico di linfociti e altre cellule mononucleate. 77
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. 76
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 76
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 76
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 75
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 75
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replicatio 75
Impact of Higly Active Antiretroviral Therapy on the Presenting Features and Outcome of Patients with Acquired Immunodeficiency Syndrome-Related Kaposi Sarcoma 74
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 72
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. 71
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. 68
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina. 68
Low prevalence of primary mutations associated with drug resistance in antiviral-naïve patients at therapy initiation 67
Loss of CD127 (Interleukin-7 receptor) expression defines an expansion of “effector memory” CD8+Tcells in HIV-infected patients 63
Il paziente adulto con immunodeficienza. 63
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from tha italian cohort of antiretroviral-naïve patients study 63
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. 60
Il ruolo del Mmg nella diagnosi precoce della malattia da HIV. 58
Identikit della immunodeficienza da HIV. 58
Infezione da HIV-1. 52
La diagnosi immunologica delle Malattie Autoimmuni non Organo Specifiche 51
L’immunoricostituzione, un paesaggio dai mutevoli confini 50
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the I.Co.N.A study 48
Totale 4.909
Categoria #
all - tutte 21.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 0 0 0 45 67 25 105 64 106 51
2021/2022441 13 96 2 61 8 21 8 43 26 56 23 84
2022/2023948 88 72 67 95 104 173 0 65 235 1 24 24
2023/2024404 85 11 17 73 70 62 8 8 0 4 12 54
2024/2025688 49 66 44 4 11 43 31 15 204 34 53 134
2025/2026741 86 121 53 166 274 41 0 0 0 0 0 0
Totale 4.909